Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient
Urinary tract infections (UTIs) maintained a serious public health concern, as did the growth in antibiotic resistance both between uropathogenic microorganisms. A regular assessment of the microbiological agents that cause UTIs, as well as their antimicrobial resistance, is essential for a tailored...
Gespeichert in:
| Veröffentlicht in: | BioMed research international 2022, Vol.2022 (1), p.4088187 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 4088187 |
| container_title | BioMed research international |
| container_volume | 2022 |
| creator | Prasada Rao, Chennu M. M. Vennila, T. Kosanam, Sreya Ponsudha, P. Suriyakrishnaan, K. Alarfaj, Abdullah A. Hirad, Abdurahman Hajinur Sundaram, S. R. Surendhar, P. A. Selvam, Nagarajan |
| description | Urinary tract infections (UTIs) maintained a serious public health concern, as did the growth in antibiotic resistance both between uropathogenic microorganisms. A regular assessment of the microbiological agents that cause UTIs, as well as their antimicrobial resistance, is essential for a tailored empirical antibiotic response. Knowing the variables that cause UTIs can help you intervene quickly and simply to get the condition under control. The most common infecting species in acute infection is Escherichia coli (E. coli). To strengthen infection control strategies, it is necessary to know the prevalence and location of UTI. The goal of this research is to measure the frequency of microorganisms isolated from patients with UTIs as well as the antimicrobial sensitivity characteristics of Gram-negative bacteria. The purpose of this research has been to evaluate the frequency of UTIs by extracting and characterizing the various bacterial etiological organisms, as well as to assess the factors linked to UTIs. The goal of this research is to identify, characterize, and establish the antibiotic susceptibility patterns of bacteria linked to urinary tract infections. Fresh collected urine specimen was taken from inpatients or outpatients in UTI cases and bacteriologically tested using conventional microbiological methods. The Kirby-Bauer disc diffusion method was used to create the antibiogram. Staphylococcus saprophyticus, Staphylococcus aureus (28%), and Escherichia coli (24.6%) were the most common isolates (20%). The evaluated agents’ antibacterial activity was all in the following order: cefixime, ciprofloxacin, augmentin, gentamicin, ceftazidime, nitrofurantoin, ofloxacin, and cefuroxime. It was discovered that each and every one of the microbes exhibited varied degrees of resistance to the antibiotics nitrofurantoin, ciprofloxacin, and ofloxacin. Every type of bacteria, with the exception of those belonging to the genus Streptococcus, has a Multiple Antibiotic Resistance Index (MARI) that is more than 0.2. The first-line therapies for urinary tract infections (UTIs) in the region would consist of ciprofloxacin, ofloxacin, and nitrofurantoin. Lower urinary tract infections almost never result in problems if they are diagnosed and treated as soon as possible and in the correct manner. However, if treatment is not sought, a urinary tract infection can lead to serious complications. |
| doi_str_mv | 10.1155/2022/4088187 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9348933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712888310</galeid><sourcerecordid>A712888310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-dd90f78d9ad6ad4b06102cd052e010a5a96e7b1cf9ec313d93b11131565ae0d33</originalsourceid><addsrcrecordid>eNp9kc9rFDEUx0OptKX25rkEvBR0bd4kk0kuwlr8sVBowfbkIWSTN92UmcmazCr-92bcda0ezCXh5fO-7_v4EvIC2BuAur6sWFVdCqYUqOaAnFQcxEyCgMP9m_NjcpbzIytHgWRaHpFjXmveCNackC_znDHnHoeRxpa-s27EFGxHFzl2dsRM2xR7Oq6Q3qcwIP28RhcKnid8Ktn0g96l0kcXQ4ul3dNbO4Yi-Jw8a22X8Wx3n5L7D-_vrj7Nrm8-Lq7m1zMnGjnOvNesbZTX1kvrxZJJYJXzrK6QAbO11RKbJbhWo-PAveZLAOBQy9oi85yfkrdb3fVm2aN3ZXSynVmn0BdzJtpg_v4Zwso8xG9Gc6E0nwQudgIpft1gHk0fssOuswPGTTaV1FpLKLYK-vIf9DFu0lDW-0XVAoTUf6gH26EJQxvLXDeJmnkDlVKKAyvU6y3lUsw5Ybu3DMxM8ZopXrOLt-DnT9fcw7_DLMCrLbAKg7ffw__lfgIQcqtr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2699541469</pqid></control><display><type>article</type><title>Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Prasada Rao, Chennu M. M. ; Vennila, T. ; Kosanam, Sreya ; Ponsudha, P. ; Suriyakrishnaan, K. ; Alarfaj, Abdullah A. ; Hirad, Abdurahman Hajinur ; Sundaram, S. R. ; Surendhar, P. A. ; Selvam, Nagarajan</creator><contributor>Kuppusamy, Ramya</contributor><creatorcontrib>Prasada Rao, Chennu M. M. ; Vennila, T. ; Kosanam, Sreya ; Ponsudha, P. ; Suriyakrishnaan, K. ; Alarfaj, Abdullah A. ; Hirad, Abdurahman Hajinur ; Sundaram, S. R. ; Surendhar, P. A. ; Selvam, Nagarajan ; Kuppusamy, Ramya</creatorcontrib><description>Urinary tract infections (UTIs) maintained a serious public health concern, as did the growth in antibiotic resistance both between uropathogenic microorganisms. A regular assessment of the microbiological agents that cause UTIs, as well as their antimicrobial resistance, is essential for a tailored empirical antibiotic response. Knowing the variables that cause UTIs can help you intervene quickly and simply to get the condition under control. The most common infecting species in acute infection is Escherichia coli (E. coli). To strengthen infection control strategies, it is necessary to know the prevalence and location of UTI. The goal of this research is to measure the frequency of microorganisms isolated from patients with UTIs as well as the antimicrobial sensitivity characteristics of Gram-negative bacteria. The purpose of this research has been to evaluate the frequency of UTIs by extracting and characterizing the various bacterial etiological organisms, as well as to assess the factors linked to UTIs. The goal of this research is to identify, characterize, and establish the antibiotic susceptibility patterns of bacteria linked to urinary tract infections. Fresh collected urine specimen was taken from inpatients or outpatients in UTI cases and bacteriologically tested using conventional microbiological methods. The Kirby-Bauer disc diffusion method was used to create the antibiogram. Staphylococcus saprophyticus, Staphylococcus aureus (28%), and Escherichia coli (24.6%) were the most common isolates (20%). The evaluated agents’ antibacterial activity was all in the following order: cefixime, ciprofloxacin, augmentin, gentamicin, ceftazidime, nitrofurantoin, ofloxacin, and cefuroxime. It was discovered that each and every one of the microbes exhibited varied degrees of resistance to the antibiotics nitrofurantoin, ciprofloxacin, and ofloxacin. Every type of bacteria, with the exception of those belonging to the genus Streptococcus, has a Multiple Antibiotic Resistance Index (MARI) that is more than 0.2. The first-line therapies for urinary tract infections (UTIs) in the region would consist of ciprofloxacin, ofloxacin, and nitrofurantoin. Lower urinary tract infections almost never result in problems if they are diagnosed and treated as soon as possible and in the correct manner. However, if treatment is not sought, a urinary tract infection can lead to serious complications.</description><identifier>ISSN: 2314-6133</identifier><identifier>ISSN: 2314-6141</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2022/4088187</identifier><identifier>PMID: 35937407</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Analysis ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterial activity ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Antimicrobial resistance ; Bacteria ; Bacteria, Pathogenic ; Bacterial infections ; Bladder ; Causes of ; Cefixime ; Ceftazidime ; Cefuroxime ; Ciprofloxacin ; Ciprofloxacin - pharmacology ; Complications ; Diagnosis ; Drug resistance ; Drug resistance in microorganisms ; Drug Resistance, Bacterial ; Drug therapy ; E coli ; Escherichia coli ; Escherichia coli Infections - drug therapy ; Etiology ; Evaluation ; Gentamicin ; Gram-negative bacteria ; Gram-positive bacteria ; Health care ; Humans ; Identification and classification ; Illnesses ; Infections ; Low income groups ; Microbial Sensitivity Tests ; Microorganisms ; Nitrofurantoin ; Ofloxacin ; Pathogens ; Patients ; Public health ; Risk factors ; Streptococcus infections ; Urinary Tract ; Urinary tract diseases ; Urinary tract infections ; Urinary Tract Infections - microbiology ; Urine ; Urogenital system</subject><ispartof>BioMed research international, 2022, Vol.2022 (1), p.4088187</ispartof><rights>Copyright © 2022 Chennu M. M. Prasada Rao et al.</rights><rights>COPYRIGHT 2022 John Wiley & Sons, Inc.</rights><rights>Copyright © 2022 Chennu M. M. Prasada Rao et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2022 Chennu M. M. Prasada Rao et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-dd90f78d9ad6ad4b06102cd052e010a5a96e7b1cf9ec313d93b11131565ae0d33</citedby><cites>FETCH-LOGICAL-c476t-dd90f78d9ad6ad4b06102cd052e010a5a96e7b1cf9ec313d93b11131565ae0d33</cites><orcidid>0000-0002-7695-0104</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348933/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348933/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35937407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Kuppusamy, Ramya</contributor><creatorcontrib>Prasada Rao, Chennu M. M.</creatorcontrib><creatorcontrib>Vennila, T.</creatorcontrib><creatorcontrib>Kosanam, Sreya</creatorcontrib><creatorcontrib>Ponsudha, P.</creatorcontrib><creatorcontrib>Suriyakrishnaan, K.</creatorcontrib><creatorcontrib>Alarfaj, Abdullah A.</creatorcontrib><creatorcontrib>Hirad, Abdurahman Hajinur</creatorcontrib><creatorcontrib>Sundaram, S. R.</creatorcontrib><creatorcontrib>Surendhar, P. A.</creatorcontrib><creatorcontrib>Selvam, Nagarajan</creatorcontrib><title>Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Urinary tract infections (UTIs) maintained a serious public health concern, as did the growth in antibiotic resistance both between uropathogenic microorganisms. A regular assessment of the microbiological agents that cause UTIs, as well as their antimicrobial resistance, is essential for a tailored empirical antibiotic response. Knowing the variables that cause UTIs can help you intervene quickly and simply to get the condition under control. The most common infecting species in acute infection is Escherichia coli (E. coli). To strengthen infection control strategies, it is necessary to know the prevalence and location of UTI. The goal of this research is to measure the frequency of microorganisms isolated from patients with UTIs as well as the antimicrobial sensitivity characteristics of Gram-negative bacteria. The purpose of this research has been to evaluate the frequency of UTIs by extracting and characterizing the various bacterial etiological organisms, as well as to assess the factors linked to UTIs. The goal of this research is to identify, characterize, and establish the antibiotic susceptibility patterns of bacteria linked to urinary tract infections. Fresh collected urine specimen was taken from inpatients or outpatients in UTI cases and bacteriologically tested using conventional microbiological methods. The Kirby-Bauer disc diffusion method was used to create the antibiogram. Staphylococcus saprophyticus, Staphylococcus aureus (28%), and Escherichia coli (24.6%) were the most common isolates (20%). The evaluated agents’ antibacterial activity was all in the following order: cefixime, ciprofloxacin, augmentin, gentamicin, ceftazidime, nitrofurantoin, ofloxacin, and cefuroxime. It was discovered that each and every one of the microbes exhibited varied degrees of resistance to the antibiotics nitrofurantoin, ciprofloxacin, and ofloxacin. Every type of bacteria, with the exception of those belonging to the genus Streptococcus, has a Multiple Antibiotic Resistance Index (MARI) that is more than 0.2. The first-line therapies for urinary tract infections (UTIs) in the region would consist of ciprofloxacin, ofloxacin, and nitrofurantoin. Lower urinary tract infections almost never result in problems if they are diagnosed and treated as soon as possible and in the correct manner. However, if treatment is not sought, a urinary tract infection can lead to serious complications.</description><subject>Analysis</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial activity</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Bacteria, Pathogenic</subject><subject>Bacterial infections</subject><subject>Bladder</subject><subject>Causes of</subject><subject>Cefixime</subject><subject>Ceftazidime</subject><subject>Cefuroxime</subject><subject>Ciprofloxacin</subject><subject>Ciprofloxacin - pharmacology</subject><subject>Complications</subject><subject>Diagnosis</subject><subject>Drug resistance</subject><subject>Drug resistance in microorganisms</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug therapy</subject><subject>E coli</subject><subject>Escherichia coli</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Etiology</subject><subject>Evaluation</subject><subject>Gentamicin</subject><subject>Gram-negative bacteria</subject><subject>Gram-positive bacteria</subject><subject>Health care</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Illnesses</subject><subject>Infections</subject><subject>Low income groups</subject><subject>Microbial Sensitivity Tests</subject><subject>Microorganisms</subject><subject>Nitrofurantoin</subject><subject>Ofloxacin</subject><subject>Pathogens</subject><subject>Patients</subject><subject>Public health</subject><subject>Risk factors</subject><subject>Streptococcus infections</subject><subject>Urinary Tract</subject><subject>Urinary tract diseases</subject><subject>Urinary tract infections</subject><subject>Urinary Tract Infections - microbiology</subject><subject>Urine</subject><subject>Urogenital system</subject><issn>2314-6133</issn><issn>2314-6141</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kc9rFDEUx0OptKX25rkEvBR0bd4kk0kuwlr8sVBowfbkIWSTN92UmcmazCr-92bcda0ezCXh5fO-7_v4EvIC2BuAur6sWFVdCqYUqOaAnFQcxEyCgMP9m_NjcpbzIytHgWRaHpFjXmveCNackC_znDHnHoeRxpa-s27EFGxHFzl2dsRM2xR7Oq6Q3qcwIP28RhcKnid8Ktn0g96l0kcXQ4ul3dNbO4Yi-Jw8a22X8Wx3n5L7D-_vrj7Nrm8-Lq7m1zMnGjnOvNesbZTX1kvrxZJJYJXzrK6QAbO11RKbJbhWo-PAveZLAOBQy9oi85yfkrdb3fVm2aN3ZXSynVmn0BdzJtpg_v4Zwso8xG9Gc6E0nwQudgIpft1gHk0fssOuswPGTTaV1FpLKLYK-vIf9DFu0lDW-0XVAoTUf6gH26EJQxvLXDeJmnkDlVKKAyvU6y3lUsw5Ybu3DMxM8ZopXrOLt-DnT9fcw7_DLMCrLbAKg7ffw__lfgIQcqtr</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Prasada Rao, Chennu M. M.</creator><creator>Vennila, T.</creator><creator>Kosanam, Sreya</creator><creator>Ponsudha, P.</creator><creator>Suriyakrishnaan, K.</creator><creator>Alarfaj, Abdullah A.</creator><creator>Hirad, Abdurahman Hajinur</creator><creator>Sundaram, S. R.</creator><creator>Surendhar, P. A.</creator><creator>Selvam, Nagarajan</creator><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7695-0104</orcidid></search><sort><creationdate>2022</creationdate><title>Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient</title><author>Prasada Rao, Chennu M. M. ; Vennila, T. ; Kosanam, Sreya ; Ponsudha, P. ; Suriyakrishnaan, K. ; Alarfaj, Abdullah A. ; Hirad, Abdurahman Hajinur ; Sundaram, S. R. ; Surendhar, P. A. ; Selvam, Nagarajan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-dd90f78d9ad6ad4b06102cd052e010a5a96e7b1cf9ec313d93b11131565ae0d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analysis</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial activity</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Bacteria, Pathogenic</topic><topic>Bacterial infections</topic><topic>Bladder</topic><topic>Causes of</topic><topic>Cefixime</topic><topic>Ceftazidime</topic><topic>Cefuroxime</topic><topic>Ciprofloxacin</topic><topic>Ciprofloxacin - pharmacology</topic><topic>Complications</topic><topic>Diagnosis</topic><topic>Drug resistance</topic><topic>Drug resistance in microorganisms</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug therapy</topic><topic>E coli</topic><topic>Escherichia coli</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Etiology</topic><topic>Evaluation</topic><topic>Gentamicin</topic><topic>Gram-negative bacteria</topic><topic>Gram-positive bacteria</topic><topic>Health care</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Illnesses</topic><topic>Infections</topic><topic>Low income groups</topic><topic>Microbial Sensitivity Tests</topic><topic>Microorganisms</topic><topic>Nitrofurantoin</topic><topic>Ofloxacin</topic><topic>Pathogens</topic><topic>Patients</topic><topic>Public health</topic><topic>Risk factors</topic><topic>Streptococcus infections</topic><topic>Urinary Tract</topic><topic>Urinary tract diseases</topic><topic>Urinary tract infections</topic><topic>Urinary Tract Infections - microbiology</topic><topic>Urine</topic><topic>Urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prasada Rao, Chennu M. M.</creatorcontrib><creatorcontrib>Vennila, T.</creatorcontrib><creatorcontrib>Kosanam, Sreya</creatorcontrib><creatorcontrib>Ponsudha, P.</creatorcontrib><creatorcontrib>Suriyakrishnaan, K.</creatorcontrib><creatorcontrib>Alarfaj, Abdullah A.</creatorcontrib><creatorcontrib>Hirad, Abdurahman Hajinur</creatorcontrib><creatorcontrib>Sundaram, S. R.</creatorcontrib><creatorcontrib>Surendhar, P. A.</creatorcontrib><creatorcontrib>Selvam, Nagarajan</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prasada Rao, Chennu M. M.</au><au>Vennila, T.</au><au>Kosanam, Sreya</au><au>Ponsudha, P.</au><au>Suriyakrishnaan, K.</au><au>Alarfaj, Abdullah A.</au><au>Hirad, Abdurahman Hajinur</au><au>Sundaram, S. R.</au><au>Surendhar, P. A.</au><au>Selvam, Nagarajan</au><au>Kuppusamy, Ramya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2022</date><risdate>2022</risdate><volume>2022</volume><issue>1</issue><spage>4088187</spage><pages>4088187-</pages><issn>2314-6133</issn><issn>2314-6141</issn><eissn>2314-6141</eissn><abstract>Urinary tract infections (UTIs) maintained a serious public health concern, as did the growth in antibiotic resistance both between uropathogenic microorganisms. A regular assessment of the microbiological agents that cause UTIs, as well as their antimicrobial resistance, is essential for a tailored empirical antibiotic response. Knowing the variables that cause UTIs can help you intervene quickly and simply to get the condition under control. The most common infecting species in acute infection is Escherichia coli (E. coli). To strengthen infection control strategies, it is necessary to know the prevalence and location of UTI. The goal of this research is to measure the frequency of microorganisms isolated from patients with UTIs as well as the antimicrobial sensitivity characteristics of Gram-negative bacteria. The purpose of this research has been to evaluate the frequency of UTIs by extracting and characterizing the various bacterial etiological organisms, as well as to assess the factors linked to UTIs. The goal of this research is to identify, characterize, and establish the antibiotic susceptibility patterns of bacteria linked to urinary tract infections. Fresh collected urine specimen was taken from inpatients or outpatients in UTI cases and bacteriologically tested using conventional microbiological methods. The Kirby-Bauer disc diffusion method was used to create the antibiogram. Staphylococcus saprophyticus, Staphylococcus aureus (28%), and Escherichia coli (24.6%) were the most common isolates (20%). The evaluated agents’ antibacterial activity was all in the following order: cefixime, ciprofloxacin, augmentin, gentamicin, ceftazidime, nitrofurantoin, ofloxacin, and cefuroxime. It was discovered that each and every one of the microbes exhibited varied degrees of resistance to the antibiotics nitrofurantoin, ciprofloxacin, and ofloxacin. Every type of bacteria, with the exception of those belonging to the genus Streptococcus, has a Multiple Antibiotic Resistance Index (MARI) that is more than 0.2. The first-line therapies for urinary tract infections (UTIs) in the region would consist of ciprofloxacin, ofloxacin, and nitrofurantoin. Lower urinary tract infections almost never result in problems if they are diagnosed and treated as soon as possible and in the correct manner. However, if treatment is not sought, a urinary tract infection can lead to serious complications.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>35937407</pmid><doi>10.1155/2022/4088187</doi><orcidid>https://orcid.org/0000-0002-7695-0104</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2314-6133 |
| ispartof | BioMed research international, 2022, Vol.2022 (1), p.4088187 |
| issn | 2314-6133 2314-6141 2314-6141 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9348933 |
| source | MEDLINE; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Analysis Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial activity Antibiotic resistance Antibiotics Antimicrobial agents Antimicrobial resistance Bacteria Bacteria, Pathogenic Bacterial infections Bladder Causes of Cefixime Ceftazidime Cefuroxime Ciprofloxacin Ciprofloxacin - pharmacology Complications Diagnosis Drug resistance Drug resistance in microorganisms Drug Resistance, Bacterial Drug therapy E coli Escherichia coli Escherichia coli Infections - drug therapy Etiology Evaluation Gentamicin Gram-negative bacteria Gram-positive bacteria Health care Humans Identification and classification Illnesses Infections Low income groups Microbial Sensitivity Tests Microorganisms Nitrofurantoin Ofloxacin Pathogens Patients Public health Risk factors Streptococcus infections Urinary Tract Urinary tract diseases Urinary tract infections Urinary Tract Infections - microbiology Urine Urogenital system |
| title | Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20Bacterial%20Isolates%20from%20the%20Urine%20Specimens%20of%20Urinary%20Tract%20Infected%20Patient&rft.jtitle=BioMed%20research%20international&rft.au=Prasada%20Rao,%20Chennu%20M.%20M.&rft.date=2022&rft.volume=2022&rft.issue=1&rft.spage=4088187&rft.pages=4088187-&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2022/4088187&rft_dat=%3Cgale_pubme%3EA712888310%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2699541469&rft_id=info:pmid/35937407&rft_galeid=A712888310&rfr_iscdi=true |